Clinical Trial Imaging Market Analysis and Scope (2023 to 2028)
Clinical Trial Imaging Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 1.61 Billion |
Market Size by 2028 | US$ 2.48 Billion |
Global CAGR (2022 - 2028) | 7.6% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Modality
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global clinical trial imaging market are listed below:
- In December 2022, Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) announced that the TCS ADD Connected Clinical Trials platform for decentralized trials, has won the India Pharma Award 2022 in the category, Excellence in Ancillary Pharma Services.
- In October 2021, Medidata, a Dassault Systèmes company, announced that Rave Imaging, the company’s cloud-based, secure clinical trial imaging management platform, has reached a significant milestone, having supported more than 1,000 imaging studies. Rave Imaging, built on the Medidata Unified Platform, processes more than 100 million images per year. The technology provides real-time visibility into all imaging-related trial activities across all Rave Imaging trials to enhance study efficiency.
Competitive Landscape and Key Companies:
The clinical trial imaging market majorly consists of players such as eResearch Technology Inc, Calyx Inc, ICON PLC, VIDA Diagnostics Inc, WCG Clinical Inc, BioTelemetry Inc, Medical Metrics Inc, Medpace Holdings Inc, Radiant Sage LLC, and IXICO plc. The companies have been implementing various strategies that have helped their growth and, in turn, have brought about various changes in the market. The companies have utilized organic strategies (such as launches, expansion, and product approvals) and inorganic strategies (such as product launches, partnerships, and collaborations).